肺癌转移所致的垂指
Drop finger caused by lung cancer metastasis.
作者信息
Sumi Toshiyuki, Sakakibara-Konishi Jun, Suzuki Keito, Chiba Hirofumi
机构信息
Department of Pulmonary Medicine Hakodate Goryoukaku Hospital Hakodate Japan.
Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine Sapporo Japan.
出版信息
Respirol Case Rep. 2024 Jan 18;12(1):e01280. doi: 10.1002/rcr2.1280. eCollection 2024 Jan.
Abstract
Skeletal muscle metastasis of lung cancer is rare. However, clinicians should be aware that tumour-induced nerve compression symptoms may develop.
摘要
肺癌的骨骼肌转移很少见。然而，临床医生应意识到可能会出现肿瘤引起的神经压迫症状。
相似文献
1
Drop finger caused by lung cancer metastasis.肺癌转移所致的垂指
Respirol Case Rep. 2024 Jan 18;12(1):e01280. doi: 10.1002/rcr2.1280. eCollection 2024 Jan.
2
Rapidly progressive squamous cell lung cancer with MET exon 14 skipping mutation metastasized to atypical bone sites - a case report.快速进展型鳞状细胞肺癌伴 MET 外显子 14 跳跃突变转移至非典型骨部位——一例报告。
Klin Onkol. 2022 Winter;35(1):72-75. doi: 10.48095/ccko202272.
3
Capmatinib in MET Exon 14 Skipping Mutation-Positive Lung Adenocarcinoma with Extensive Central Nervous System Metastasis.卡马替尼用于治疗伴有广泛中枢神经系统转移的MET外显子14跳跃突变阳性肺腺癌。
Onco Targets Ther. 2022 Aug 31;15:941-946. doi: 10.2147/OTT.S382722. eCollection 2022.
4
[Expert Consensus on Targeted Therapy of NSCLC with MET Exon 14
Skipping Mutation].《非小细胞肺癌MET外显子14跳跃突变靶向治疗专家共识》
Zhongguo Fei Ai Za Zhi. 2023 Jun 20;26(6):416-428. doi: 10.3779/j.issn.1009-3419.2023.102.19.
5
Mesenchymal-Epithelial Transition Exon 14 Skipping Mutation and Amplification in 5,008 Patients With Lung Cancer.5008例肺癌患者中14号外显子跳跃突变及间充质-上皮转化基因扩增情况
Front Oncol. 2021 Sep 30;11:755031. doi: 10.3389/fonc.2021.755031. eCollection 2021.
6
Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation.替波替尼治疗伴有 MET 外显子 14 跳跃突变的非小细胞肺癌脑膜转移的活性和生物利用度。
Cancer Commun (Lond). 2021 Jan;41(1):83-87. doi: 10.1002/cac2.12124. Epub 2021 Jan 2.
7
Responses to crizotinib and cabozantinib in patient with lung adenocarcinoma harboring mesenchymal-epithelial transition factor exon 14 skipping mutation: A case report.携带有间充质-上皮转化因子外显子 14 跳跃突变的肺腺癌患者对克唑替尼和卡博替尼的反应：一例报告。
Medicine (Baltimore). 2021 Jan 29;100(4):e24300. doi: 10.1097/MD.0000000000024300.
8
Survival outcomes and prognostic factors of lung cancer patients with the exon 14 skipping mutation: A single-center real-world study.具有外显子14跳跃突变的肺癌患者的生存结果和预后因素：一项单中心真实世界研究。
Front Oncol. 2023 Mar 9;13:1113696. doi: 10.3389/fonc.2023.1113696. eCollection 2023.
9
Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline Exon 14 Skipping Mutation: A Case Report.携带胚系外显子14跳跃突变的晚期非小细胞肺癌患者疾病快速进展：一例报告
Onco Targets Ther. 2021 Apr 7;14:2417-2421. doi: 10.2147/OTT.S295542. eCollection 2021.
10
Responses to crizotinib and disease monitoring with circulating tumor cells in lung adenocarcinoma patient with MET exon 14 skipping mutation: A case report.MET外显子14跳跃突变的肺腺癌患者对克唑替尼的反应及循环肿瘤细胞监测：一例报告
Medicine (Baltimore). 2017 Nov;96(47):e8744. doi: 10.1097/MD.0000000000008744.
本文引用的文献
1
Isolated spontaneous posterior interosseous nerve palsy: a review of aetiology and management.孤立性自发性骨间后神经麻痹：病因与治疗综述
J Hand Surg Eur Vol. 2019 Mar;44(3):310-316. doi: 10.1177/1753193418813788. Epub 2018 Dec 3.
Zotero 插件